Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,855 | -40,106 | -22,214 | -103,238 | -78,666 |
| Depreciation Amortization | 2,207 | 1,474 | 727 | 2,457 | 1,731 |
| Accounts receivable | -18 | -24 | -10 | 183 | 169 |
| Accounts payable and accrued liabilities | -538 | -1,541 | -1,444 | -742 | -981 |
| Other Working Capital | -533 | -1,916 | -1,762 | -716 | -2,704 |
| Other Operating Activity | 20,575 | 13,040 | 8,341 | 31,071 | 26,289 |
| Operating Cash Flow | $-40,162 | $-29,073 | $-16,362 | $-70,985 | $-54,162 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -59 | -41 | -26 | -1,540 | -1,242 |
| Net Acquisitions | N/A | N/A | N/A | -3,200 | -3,200 |
| Purchase Sale Intangibles | 1,000 | 1,000 | 1,000 | N/A | N/A |
| Other Investing Activity | 1,000 | 1,000 | 1,000 | 0 | 0 |
| Investing Cash Flow | $941 | $959 | $974 | $-4,740 | $-4,442 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 10,000 | 35,227 | 35,227 |
| Common Stock Issued | 2,260 | 1,908 | 1,299 | 3,350 | 3,270 |
| Common Stock Repurchased | N/A | N/A | N/A | -366 | -366 |
| Other Financing Activity | 13,625 | 13,625 | 13,625 | 0 | 0 |
| Financing Cash Flow | $25,885 | $25,533 | $24,924 | $38,211 | $38,131 |
| Beginning Cash Position | 39,744 | 39,744 | 39,744 | 77,258 | 77,258 |
| End Cash Position | 26,408 | 37,163 | 49,280 | 39,744 | 56,785 |
| Net Cash Flow | $-13,336 | $-2,581 | $9,536 | $-37,514 | $-20,473 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,162 | -29,073 | -16,362 | -70,985 | -54,162 |
| Capital Expenditure | -59 | -41 | -26 | -1,540 | -1,242 |
| Free Cash Flow | -40,221 | -29,114 | -16,388 | -72,525 | -55,404 |